» Articles » PMID: 16883065

NKT Cells in the Induced Sputum of Severe Asthmatics

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2006 Aug 3
PMID 16883065
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To determine whether there was a specific inflammatory process in severe asthmatics, the phenotypic characteristics of induced sputum immune cells were analysed among patients with severe asthma. Twenty-two induced sputa (10 severe asthmatics) were studied. Flow cytometric analysis was performed using immune cells of the sputum and monoclonal antibodies to CD3, CD4, CD8, CD56, CD25, and TCRgammadelta. The number of NKT (CD3(+) CD56(+)) cells was significantly higher in the sputum of severe asthmatics compared with mild asthmatic and healthy control groups (P < .05). CD8(+)CD56(+) cells were the predominant subtype of the increased NKT cells in severe asthmatics. CD3(+)CD56(+)Valpha24(+), TCRgammadelta(+) CD56(+), and CD4(+)CD25(+) T cells were significantly increased in severe asthmatic patients. These results suggest that the immunopathogenesis of severe asthmatics vary between severe and mild asthmatics, and that CD8(+)CD56(+) NKT cells may play an important role in the immunopathogenesis of severe asthma.

Citing Articles

Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies.

Gutierrez-Vera C, Garcia-Betancourt R, Palacios P, Muller M, Montero D, Verdugo C Front Immunol. 2024; 15:1364774.

PMID: 38629075 PMC: 11018981. DOI: 10.3389/fimmu.2024.1364774.


De novo fatty-acid synthesis protects invariant NKT cells from cell death, thereby promoting their homeostasis and pathogenic roles in airway hyperresponsiveness.

Koh J, Woo Y, Yoo H, Choi J, Kim S, Chang Y Elife. 2023; 12.

PMID: 37917548 PMC: 10622147. DOI: 10.7554/eLife.87536.


Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice.

Licari A, Manti S, Castagnoli R, Leonardi S, Marseglia G Breathe (Sheff). 2020; 16(1):190301.

PMID: 32494300 PMC: 7249787. DOI: 10.1183/20734735.0301-2019.


Role of CD1d- and MR1-Restricted T Cells in Asthma.

Iwamura C, Nakayama T Front Immunol. 2018; 9:1942.

PMID: 30210497 PMC: 6121007. DOI: 10.3389/fimmu.2018.01942.


Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment.

Chandra S, Wingender G, Greenbaum J, Khurana A, Gholami A, Ganesan A J Immunol. 2018; 200(6):1995-2003.

PMID: 29431692 PMC: 5840005. DOI: 10.4049/jimmunol.1701525.


References
1.
Jatakanon A, Uasuf C, Maziak W, Lim S, Chung K, Barnes P . Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999; 160(5 Pt 1):1532-9. DOI: 10.1164/ajrccm.160.5.9806170. View

2.
Hamzaoui A, Chaouch N, Grairi H, Ammar J, Hamzaoui K . Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients. Mediators Inflamm. 2005; 2005(3):160-6. PMC: 1526471. DOI: 10.1155/MI.2005.160. View

3.
Hayday A . [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000; 18:975-1026. DOI: 10.1146/annurev.immunol.18.1.975. View

4.
Muro S, Minshall E, Hamid Q . The pathology of chronic asthma. Clin Chest Med. 2000; 21(2):225-44. DOI: 10.1016/s0272-5231(05)70263-x. View

5.
Colavita A, Reinach A, Peters S . Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm. Clin Chest Med. 2000; 21(2):263-77, viii. DOI: 10.1016/s0272-5231(05)70265-3. View